Acquired Immunodeficiency Syndrome (AIDS) is a complex and advanced stage of HIV (Human Immunodeficiency Virus) infection, characterized by severe damage to the immune system. HIV attacks and weakens the immune system's CD4 T cells, leaving the body susceptible to opportunistic infections and certain cancers. The progression to AIDS typically occurs when the CD4 count drops below a critical level or when specific AIDS-defining illnesses manifest. AIDS-defining conditions include opportunistic infections like Pneumocystis pneumonia, tuberculosis, and cytomegalovirus, as well as certain cancers like Kaposi's sarcoma and lymphomas. Individuals with AIDS are also at heightened risk of neurological complications, such as HIV-associated dementia. Antiretroviral therapy (ART) is the cornerstone of AIDS management, suppressing viral replication and slowing disease progression. Early diagnosis and consistent adherence to ART can significantly prolong and improve the quality of life for those living with HIV/AIDS. Nevertheless, addressing the broader social determinants of health, reducing stigma, and promoting preventive measures remain crucial in the global effort to control and ultimately eradicate AIDS.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain